Medicalgorithmics S.A. — Report Publication Announcement 2023

Jun 15, 2023

Current Report No.14/2023

Date of preparation: 2023-06-14

Abbreviated name of the issuer: MEDICALGORITHMICS S.A.

Subject: Admission and conditional introduction of the Company's seriesI shares to trading on the main market of the WSE. Setting the date ofthe first listing of the Company's series I shares after theirassimilation with shares traded on the main market.

Legal basis: Art. 56 (1) (2) of the Act on Offering - current andperiodic information.

Contents of the report:

The Management Board of MEDICALGORITHMICS S.A. with its seat in Warsaw[Issuer, Company], hereby informs that on June 14, 2023 it receivedinformation on the adoption of Resolution No. 562/2023 of the ManagementBoard of the Warsaw Stock Exchange on June 14, 2023 [WSE] regarding theadmission and introduction to trading on the WSE Main Market of series Iordinary bearer shares of the Company [Resolution].

Pursuant to the Resolution, 995,276 [nine hundred and ninety-fivethousand two hundred and seventy-six] series I bearer common shares ofthe Company carrying ISIN code PLMDCLG00031 [Shares], with a nominalvalue of 0.10 [ten grosz] each, were admitted to trading on the mainmarket._#160;

Pursuant to the Resolution, the Shares will be listed on the main marketas of June 21, 2023, subject to the assimilation of the Shares by theNational Securities Depository S.A. [Krajowy Depozyt PapierówWartościowych SA] on June 21, 2023 with the Company's shares traded onthe stock exchange, under the code PLMDCLG00015. The Company willannounce the assimilation of the Shares in a separate current report.

The Company reminds that the Shares were issued in accordance with theResolution No. 4 of the Company's Extraordinary General Meeting ofOctober 28, 2022 Increase of the Company's share capital through issueof series I, J, K and L shares; waiver of existing shareholders'subscription rights; private subscription offer for a designated entity;and change of Article 5 (1) and (2) of the Articles of Association. Theshares were registered with the National Securities Depository on March7, 2023, as the Company announced in current report number 8/2023 onMarch 8, 2023.

The Company remindsthat in the current report No. 55/2022 it informed on October 1, 2022that 4,976,384 Shares were acquired by Biofund Capital Management LLCwith its registered office in Miami (USA). These shares are to beintroduced to trading under the applicable exceptions to the obligationto prepare an issue prospectus, and the planned date of introducing allthese shares to trading has been set at the end of 2026.